GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.05.25	GSK Plc: CHMP Recommends Approval Of Blenrep Combinations (RTTNews)
23.05.25	GSK : FDA Approves Nucala As Add-on Maintenance Treatment For Chronic Obstructive Pulmonary Disease (RTTNews)
19.05.25	GSK: Japan Approves Blenrep Combinations To Treat Relapsed/refractory Multiple Myeloma In Adults (RTTNews)
14.05.25	GSK Acquires BP Asset IX Inc. For $2 Bln To Advance Efimosfermin In SLD Treatment (RTTNews)
02.03.23	FDA Panel Backs GSK's RSV Vaccine For Older Adults (RTTNews)
10.02.23	GSK Plc: FDA Grants Approval For Jemperli For Patients With DMMR Recurrent Endometrial Cancer (RTTNews)
10.02.23	US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer (PR Newswire)
11.07.22	GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses (Businesswire)
29.06.22	GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community (Businesswire)
06.06.22	GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older (Businesswire)
07.06.19	GSK: Nucala Gets FDA Approval For Two New Self-administration Options (RTTNews)
16.05.19	Thermo Fisher To Buy GSK's API Manufacturing Site In Cork, Ireland For €90 Mln (RTTNews)
01.05.19	GSK Q1 Profit Rises (RTTNews)
29.04.19	ViiV Healthcare Seeks FDA Approval For Two-drug To Treat HIV-1 Infection (RTTNews)
24.04.19	World's First Malaria Vaccine Launched (RTTNews)
18.04.19	Mustang Bio Gallops On Gene Therapy Trial Results For Bubble Boy Disease (RTTNews)
18.04.19	The First Two-Drug Regimen For New HIV Patients (RTTNews)
09.04.19	CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub (RTTNews)
09.04.19	GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts (RTTNews)
29.07.15	GlaxoSmithKline Profit Drops, But Tops View - Update (RTTNews)
29.07.15	GSK Q2 Pre-tax Profit Plunges, Revenue Up - Quick Facts (RTTNews)
24.07.15	GSK' Malaria Vaccine Containing Agenus'QS-21 Stimulon Gets Positive CHMP Opinion (RTTNews)
17.04.15	SSH Shines, First Generic MS Drug Approved, MNOV On Fast Track, ALDX On Watch (RTTNews)
18.12.14	GlaxoSmithKline Shareholders Pass Deal With Novartis By Overwhelming Majority (RTTNews)
18.12.14	Agenus: GSK's ZOE-50 Phase 3 Study Meets Primary Endpoint - Quick Facts (RTTNews)
05.12.14	GSK Abandons Sale Of Established Products Portfolio (RTTNews)
04.12.14	Array BioPharma To Regain Worldwide Rights To Binimetinib (RTTNews)
04.12.14	Glaxo To Lay Off Hundreds Of Workers In The U.S. (RTTNews)
30.11.14	Bloomberg: GlaxoSmithKline To Cut U.S. Jobs Amid Restructuring (RTTNews)
27.11.14	U.S. FTC Votes FOR GSK's Proposed Novartis Transaction Approval - Quick Facts (RTTNews)
18.11.14	Ablynx Appoints GSK's Johan Heylen As Chief Commercial Officer - Quick Facts (RTTNews)
18.11.14	ACT Buys AGN, NBS Needs A Close Watch, No Pain For TRVN, TKMR Does A Deal (RTTNews)
17.11.14	Medidata Joins With GlaxoSmithKline On Mobile Health Initiative (RTTNews)
12.11.14	GSK Reports EU Submission For Severe Aplastic Anemia Indication For Revolade (RTTNews)
05.11.14	GSK Files For Approval Of Mepolizumab In US, Europe For Eosinophilic Asthma (RTTNews)
03.11.14	Genmab Reaches Deal To Transfer Ofatumumab Collaboration With GSK To Novartis (RTTNews)
24.10.14	Five Prime Therapeutics Expands Collaboration With GSK (RTTNews)
22.10.14	GSK Profit Falls; Plans Partial IPO Of ViiV Business - Update (RTTNews)
09.10.14	Isis Pharma Earns $18 Mln From GSK For Advancing ISIS-TTR Rx - Quick Facts (RTTNews)
08.10.14	Novartis Unveils Executive Committee Changes Post Portfolio Transactions (RTTNews)
01.10.14	Isis Pharma Earns $1.5 Mln From GSK For The Advancement Of ISIS-GSK4 Rx (RTTNews)
30.09.14	GE Healthcare, Glaxo To Collaborate On Commercial Oncology Testing (RTTNews)
24.09.14	Glaxo Reportedly Set To Name Philip Hampton As Chairman (RTTNews)
19.09.14	GSK China Unit Ordered To Pay GBP 297 Mln Fine For Bribery (RTTNews)
16.09.14	Mylan To Commence Phase III Trial For Its Generic Version Of Advair Diskus (RTTNews)
15.09.14	Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target (RTTNews)
08.09.14	Gilead: AMBITION Study Of Ambrisentan/Tadalafil Achieves Primary Endpoint (RTTNews)
27.08.14	Ligand's Partner GSK Gets FDA Approval Of SNDA For Promacta/Revolade (RTTNews)
27.08.14	GSK: FDA OKs Promacta SNDA In Patients With Aplastic Anaemia (RTTNews)
20.08.14	GSK Gets FDA Approval For Asthma Drug Arnuity Ellipta (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft

10.02.22

CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat

09.02.22

GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Geberit	608.20	0.33 %	K V
Swisscom	565.50	-0.26 %	K V
Roche Hldg G	260.20	-0.27 %	K V
Part Grp Hldg	1’093.50	-0.36 %	K V
Zurich Insur Gr	576.60	-0.93 %	K V
Swiss Life Hldg	816.20	-1.52 %	K V
Swiss Re	145.55	-1.85 %	K V
Alcon	70.56	-1.95 %	K V
Sonova Hldg	257.70	-2.05 %	K V
CieFinRichemont	155.90	-2.38 %	K V

GlaxoSmithKline Aktie VALOR 334234 / ISIN US37733W1053

Nachrichten zu GlaxoSmithKline plc (GSK) (ADRS)

Aktien Top/Flop

GlaxoSmithKline Peer Group Nachrichten

Meistgelesene Nachrichten